Market Tracker

10/21 7:44am ET

Vanguard Health Care Index Fund ETF Shares (VHT)

113.93
Data as of Oct 20
 +1.37 / +1.22%
Today’s Change
95.69
Today|||52-Week Range
119.78
+12.69%
Year-to-Date

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). It attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

No recent news for Vanguard Health Care Index Fund ETF Shares.

Performance

1 month-4.28% 3 years+27.01%
3 months+1.75% 5 years+19.03%
1 year+19.39% Since inception+9.27%
Data through 10/21/2014

Quote Details

Previous close$112.56
Open day’s range-- – --
Net asset value (NAV)113.89 (10/20/2014)
Daily volume1,462,089
Average volume (3 months)258,653
Data as of 10/20/2014

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+19.03%+21.83%
Expense Gross exp ratio0.14%0.42%
Risk 5 year sharpe ratio1.561.39
Net assets$3.9B$1.5B
Average market cap$48.2B$27.2B
Average P/E24.929.1
Dividend / Share--0.20%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
XHS SPDR® S&P Health Care Services ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson10.37%
PFE Pfizer Inc6.48%
MRK Merck & Co Inc5.96%
GILD Gilead Sciences Inc5.62%
AMGN Amgen Inc3.67%
ABBV AbbVie Inc3.17%
BMY Bristol-Myers Squibb Company2.92%
UNH UnitedHealth Group Inc2.91%
BIIB Biogen Idec Inc2.71%
CELG Celgene Corp2.62%